PANCREATIC FUNCTION AND DISEASE IN EARLY LIFE
- 1 October 1943
- journal article
- research article
- Published by American Medical Association (AMA) in American Journal of Diseases of Children
- Vol. 66 (4) , 370-375
- https://doi.org/10.1001/archpedi.1943.02010220023003
Abstract
The use of secretin as a test substance for the study of pancreatic function has increased extensively in recent years but has been limited, as far as can be determined, to normal adults and to adult patients.1 The studies reported here were carried out to supply data concerning the effect of secretin on the pancreatic function of infants and children and to ascertain its usefulness as a diagnostic aid in studies of pancreatic disease in early life. The discovery by Bayliss and Starling in 1902 of the hormone secretin was followed by numerous unsuccessful attempts to make clinical use of this observation.1a The recent isolation of secretin from the intestinal mucosa as a crystalline salt, by Hammarsten, and the preparation by Agren of a substance suitable for clinical work have permitted a number of investigations of the action of secretin within the last few years.1a As observedThis publication has 1 reference indexed in Scilit:
- PANCREATIC DISEASEJAMA, 1942